utrophin

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of an AI semiconductor chip and data center infrastructure as Marvell Technology’s S&P 500 entry puts MRVL stock, AI chip valuations, and index-fund demand in sharper investor focus.

Is Marvell Technology’s S&P 500 inclusion a reward for AI growth or a valuation warning?

Representative image of a modern urban hotel in Ahmedabad, where Royal Orchid Hotels’ Z by Regenta expansion highlights ROHLTD’s push into Gujarat’s lifestyle hospitality market.

Is Royal Orchid Hotels using Ahmedabad to prove its lifestyle hotel play can scale faster?

Representative image of a premium hill resort in Mussoorie for Leisure Hotels Group Samsara Hill Resort story.

Can Samsara Hill Resort help Leisure Hotels Group turn Mussoorie pressure into premium pricing power?

Representative image of underground HVDC cable construction and wind power infrastructure, highlighting how Germany’s A-Nord project aims to connect northern renewable energy with western industrial demand centres.

A-Nord HVDC project: Why Germany’s 2GW wind power corridor matters in 2026

Atossa Therapeutics (NASDAQ: ATOS) expands (Z)-endoxifen to DMD: Will investors buy the thesis?

Atossa Therapeutics eyes new ground in DMD care with (Z)-endoxifen. Find out how this small molecule could reshape treatment for carriers and boys alike.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

November 17, 2025